CytoDyn Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
CytoDyn Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2020 to Q4 2024.
  • CytoDyn Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending November 30, 2024 was 1.22B shares, a 27.4% increase year-over-year.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 970M shares, a 15.9% increase from 2022.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 837M shares, a 23.6% increase from 2021.
  • CytoDyn Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 677M shares, a 15.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 1.22B +262M +27.4% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-14
Q3 2024 1.2B +275M +29.7% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q2 2024 970M +133M +15.9% Mar 1, 2024 May 31, 2024 10-K 2024-08-15
Q1 2024 982M +150M +18% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 959M +146M +17.9% Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-14
Q3 2023 924M +136M +17.2% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
Q2 2023 837M +160M +23.6% Mar 1, 2023 May 31, 2023 10-K 2024-08-15
Q1 2023 832M +137M +19.6% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 813M +151M +22.8% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-16
Q3 2022 788M +155M +24.5% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-23
Q2 2022 677M Mar 1, 2022 May 31, 2022 10-K 2023-09-14
Q1 2022 696M +695M Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-10
Q4 2021 663M +84.7M +14.6% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-09
Q3 2021 633M Jun 1, 2021 Aug 31, 2021 10-Q/A 2022-10-13
Q1 2021 578K* Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-11
Q4 2020 578M Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.